Company: NCEL
Filing Date: 2025-05-05
Form Type: 6-K
Source: 0001213900-25-039691
Chunk: 3

Company: NewcelX Ltd.
Filing Date: 2025-05-05
Form: 6-K
Chunk 3
---
 this report is submitted, to the extent
not superseded by documents or reports subsequently filed or furnished.

<div align='center'>2

EXHIBIT INDEX</div>

<div align='center'>3

SIGNATURES</div>

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

| Date: May 5, 2025 | NLS Pharmaceutics Ltd. 
 By:                    | /s/ Alexander Zwyer |                         |
|:------------------|:-----------------------|:--------------------|:------------------------|
|                   |                        | Name:               | Alexander Zwyer         |
|                   |                        | Title:              | Chief Executive Officer |

<div align='center'>4</div>